The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

Jay Bhattacharya is director of the National Institutes of Health.

mRNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research. His case fell far short.

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...

In this week’s InnovationRx newsletter, we look at longevity drugs for dogs, programmable mRNA for fighting cancer, AI models ...

This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious disease physician Jake Scott.